C M Bidwell & Associates LTD Akero Therapeutics, Inc. Transaction History

C M Bidwell & Associates LTD

  • $162 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$24.81 - $32.35 $166,351 - $216,906
-6,705 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$24.04 - $34.19 $42,070 - $59,832
1,750 Added 35.32%
6,705 $195,000
Q4 2020

Feb 16, 2021
BUY
$25.12 - $29.89 $124,469 - $148,104
4,955 New
4,955 $128,000

Others Institutions Holding AKRO

# of Institutions
190
Shares Held
73.8M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.33B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email